What potential is there for liposomal-based nanotherapy for the treatment of Type 1 diabetes?
Nanomedicine (Lond)
.
2015 Oct;10(19):2955-2958.
doi: 10.2217/nnm.15.140.
Epub 2015 Sep 30.
Authors
Marta Vives-Pi
1
,
Irma Pujol-Autonell
1
Affiliation
1
Immunology Department, CIBER of Diabetes & Associated Metabolic Diseases (CIBERDEM), Germans Trias i Pujol Research Institute, Universitat Autonoma de Barcelona, Badalona, Spain.
PMID:
26419917
DOI:
10.2217/nnm.15.140
No abstract available
Keywords:
Type 1 diabetes; autoimmunity; immunotherapy; liposomes; nanomedicine.